Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.93B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$297M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$219M |
| 4 |
Johnson & Johnson
JNJ
|
+$210M |
| 5 |
iShares MSCI China ETF
MCHI
|
+$207M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INP
iPath ETNs Linked to the MSCI India Total Return Index
INP
|
+$1.2B |
| 2 |
Bausch Health
BHC
|
+$484M |
| 3 |
EVHC
Envision Healthcare Holdings Inc
EVHC
|
+$333M |
| 4 |
AT&T
T
|
+$279M |
| 5 |
LO
LORILLARD INC COM STK
LO
|
+$255M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 6.63% |
| 2 | Technology | 4.94% |
| 3 | Financials | 3.76% |
| 4 | Energy | 3.19% |
| 5 | Industrials | 2.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
JPXN
3551
iShares JPX-Nikkei 400 ETF
JPXN
$140M
| $402K | ﹤0.01% |
7,320
| – | – |
|
|
TXNM
3552
TXNM Energy Inc
TXNM
$5.94B
| $402K | ﹤0.01% |
16,740
-4,039
| -19% | -$108K |
|
|
GPP
3553
DELISTED
Green Plains Partners LP
GPP
| $402K | ﹤0.01% |
+26,800
| New | +$415K |
|
|
KKD
3554
CALL
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $401K | ﹤0.01% |
21,100
+2,100
| +11% | +$39K |
|
3555
iShares MSCI Switzerland ETF
EWL
$2.23B
| $400K | ﹤0.01% |
12,520
-1,560
| -11% | -$54.3K |
|
3556
CALL
IMAX
IMAX
$2.66B
| $400K | ﹤0.01% |
10,000
+8,400
| +525% | +$326K |
|
3557
VanEck Agribusiness ETF
MOO
$969M
| $400K | ﹤0.01% |
7,267
-3,765
| -34% | -$210K |
|
|
RUSS
3558
PUT
DELISTED
Direxion Daily Russia Bear 3x Shares
RUSS
| $400K | ﹤0.01% |
+2,500
| New | +$381K |
|
3559
PUT
Exelixis
EXEL
$13.4B
| $399K | ﹤0.01% |
133,100
+129,800
| +3,933% | +$422K |
|
3560
CALL
NewMarket
NEU
$8.18B
| $399K | ﹤0.01% |
900
-1,700
| -65% | -$782K |
|
|
OSIR
3561
DELISTED
Osiris Therapeutics, Inc. Common Stock
OSIR
| $399K | ﹤0.01% |
20,981
+17,570
| +515% | +$311K |
|
3562
BBVA Argentina
BBAR
$3.49B
| $398K | ﹤0.01% |
26,522
-889
| -3% | -$16.4K |
|
3563
CALL
ProShares Ultra Russell2000
UWM
$249M
| $398K | ﹤0.01% |
16,400
+12,800
| +356% | +$314K |
|
3564
CALL
Western Union
WU
$2.21B
| $398K | ﹤0.01% |
19,900
+7,400
| +59% | +$158K |
|
|
HUB.A
3565
DELISTED
HUBBELL INC CL-A
HUB.A
| $398K | ﹤0.01% |
+3,715
| New | +$417K |
|
|
ZSPH
3566
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $398K | ﹤0.01% |
7,646
+7,169
| +1,503% | +$353K |
|
3567
CALL
Church & Dwight Co
CHD
$24.5B
| $397K | ﹤0.01% |
9,800
+5,000
| +104% | +$209K |
|
|
ESPR
3568
DELISTED
Esperion Therapeutics
ESPR
| $397K | ﹤0.01% |
4,903
+3,754
| +327% | +$367K |
|
3569
CALL
iShares North American Natural Resources ETF
IGE
$758M
| $396K | ﹤0.01% |
11,000
+9,000
| +450% | +$348K |
|
3570
CALL
Winnebago Industries
WGO
$909M
| $396K | ﹤0.01% |
17,200
+6,400
| +59% | +$136K |
|
3571
PUT
Ingredion
INGR
$6.58B
| $395K | ﹤0.01% |
5,000
+4,700
| +1,567% | +$378K |
|
3572
PUT
Nektar Therapeutics
NKTR
$2.58B
| $395K | ﹤0.01% |
2,193
-5,894
| -73% | -$1.01M |
|
3573
CALL
WisdomTree
WT
$3.22B
| $395K | ﹤0.01% |
18,800
+16,200
| +623% | +$342K |
|
|
VVUS
3574
CALL
DELISTED
Vivus Inc
VVUS
| $395K | ﹤0.01% |
19,770
+16,810
| +568% | +$413K |
|
3575
Emergent Biosolutions
EBS
$248M
| $393K | ﹤0.01% |
12,307
+11,226
| +1,038% | +$348K |
|
Similar funds
Barclays's Q2 2015 Portfolio in Review
As of Q2 2015, Barclays held 7,557 positions worth $89.1B, up 2.7% from $86.7B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays's Q2 2015 filing shows 425 new, 2,570 increased, 3,770 reduced and 450 closed positions. Its largest new stake was Element Solutions: 801,973 shares worth $20M. The largest sale was iPath ETNs Linked to the MSCI India Total Return Index, an estimated $1.2B.
By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, down from 7.6% a quarter earlier, followed by Technology and Financials.
- Barclays's largest Q2 2015 buy was Element Solutions: 801,973 shares worth $20M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q2 2015, an estimated $2.93B increase.
- Barclays's biggest Q2 2015 reduction was Bausch Health, cutting an estimated $484M.
- Barclays fully exited iPath ETNs Linked to the MSCI India Total Return Index in Q2 2015, selling an estimated $1.2B.
- Barclays's ten largest holdings make up 31% of its $89.1B portfolio in Q2 2015.
- Barclays opened 425 new positions and closed 450 in Q2 2015.
- Barclays's portfolio value rose 2.7% quarter-over-quarter to $89.1B.
Based on Barclays's 13F filing for Q2 2015, filed 14 Aug 2015.